Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Republicans Pledge To Build Up Stockpiles Of COVID-19 Diagnostics, Supplies, Under HEALS Act

But House Democrats earmarked much higher levels of funding to supplement the Strategic National Stockpile and $75bn for testing and contact tracing in May HEROES Act

Executive Summary

One of eight legislative bills put out by GOP senators under the umbrella of the HEALS Act coronavirus relief package on 27 July would build up stockpiles of diagnostics and medical supplies.

You may also be interested in...



Senate GOP Coughs Up Only $16Bn For COVID-19 Testing In ‘Emaciated’ Relief Package

The US Senate will vote Thursday on its slimmed-down coronavirus pandemic relief package, Senate Majority Leader Mitch McConnell says.

COVID-19 Or Co-Pays: Which Is More Complex?

One of many unresolved issues for the next round of COVID-19 response legislation in the US is whether and how to assure that an eventual vaccine is affordable for all Americans. The House wants to make it free to everyone – which is a lot harder than it sounds.

Trump Should Have Focused On National COVID-19 Testing Plan, US House Says In ‘Failure To Lead’ Report

President Trump has failed to use appropriate legal authorities to fight the coronavirus, US House leaders say in a new report.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT142503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel